Laurion Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-337,109
| Closed | -$15.1M | – | 579 |
|
|
2021
Q2 | $15.1M | Buy |
337,109
+189,704
| +129% | +$8.51M | 0.08% | 51 |
|
|
2021
Q1 | $3.82M | Buy |
147,405
+17,247
| +13% | +$447K | 0.02% | 180 |
|
|
2020
Q4 | $2.62M | Buy |
+130,158
| New | +$2.62M | 0.02% | 136 |
|
|
2019
Q2 | – | Sell |
-85,641
| Closed | -$1.08M | – | 783 |
|
|
2019
Q1 | $1.08M | Buy |
85,641
+68,541
| +401% | +$862K | 0.01% | 277 |
|
|
2018
Q4 | $115K | Sell |
17,100
-48,342
| -74% | -$325K | ﹤0.01% | 633 |
|
|
2018
Q3 | $673K | Buy |
+65,442
| New | +$673K | 0.01% | 398 |
|